Ticker Details
EyePoint Pharmaceuticals, Inc. Common Stock
IPO Date:	February 1, 2005
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$1.27B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 3.76%
Avg Daily Range (30 D):	$0.61 | 4.18%
Avg Daily Range (90 D):	$0.51 | 3.59%

Institutional Daily Volume
Avg Daily Volume:	.41M
Avg Daily Volume (30 D):	1.25M
Avg Daily Volume (90 D):	1.15M

Trade Size
Avg Trade Size (Sh.):	80
Avg Trade Size (Sh.) (30 D):	71
Avg Trade Size (Sh.) (90 D):	70

Institutional Trades
Total Institutional Trades:	931
Avg Institutional Trade:	$1.57M
Avg Institutional Trade (30 D):	$1.53M
Avg Institutional Trade (90 D):	$1.71M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.66M
Avg Closing Trade (30 D):	$1.95M
Avg Closing Trade (90 D):	$2.17M
Avg Closing Volume:	127.1K

News

Feb 18, 2026 @ 12:00 PM EyePoint Appoints Michael Campbell as Chief Commer... Source: Eyepoint, Inc.

Jan 16, 2026 @ 12:00 PM EyePoint Reports Inducement Grants Under NASDAQ Li... Source: Na

Jan 7, 2026 @ 12:00 PM EyePoint Reports Corporate Update and Anticipated ... Source: Eyepoint, Inc.

Nov 19, 2025 @ 12:00 PM EyePoint Announces Positive Recommendation from In... Source: Eyepoint Pharmaceuticals

Nov 5, 2025 @ 12:00 PM EyePoint Reports Third Quarter 2025 Financial Resu... Source: Eyepoint Pharmaceuticals

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.85	$-.85	$-.65
Diluted EPS	$-.85	$-.85	$-.65
Revenue	$.97M	$5.33M	$24.45M
Gross Profit
Net Income / Loss	$-59.73M	$-59.43M	$-45.2M
Operating Income / Loss	$-62.03M	$-62.23M	$-48.84M
Cost of Revenue
Net Cash Flow	$3.43M	$-14.02M	$-14.55M
PE Ratio

Splits
Dec 09, 2020	1:10
Jun 11, 2008	1:4